Green Cross Medical Science financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩81.33B | ₩89.30B | ₩86.16B | ₩98.39B | ₩86.32B | ₩81.49B | ₩113.38B | ₩101.67B | ₩113.11B | ₩94.01B | ₩0.00M |
| GM % | Gross Margin % |
|
18.35% | 14.94% | 14.42% | 15.60% | 9.41% | 11.39% | 17.44% | 1.60% | 11.27% | 14.84% | 0.00% |
| OM | Operating Margin |
|
5.47% | 1.55% | -2.26% | 0.45% | -6.75% | -3.70% | 3.70% | -19.83% | -1.60% | 1.35% | 0.00% |
| EPS | Earnings Per Share |
|
₩112.23 | ₩0.00 | |||||||||
| Div. | Dividends |
|
₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00% | 0 |
| Sha. | Shares |
|
9.56m | 9.56m | 9.56m | 9.56m | 9.56m | 21.07m | 21.07m | 21.07m | 21.08m | 21.08m | 21.1m |
| OCF | Operating Cash Flow |
|
₩-2217.65M | ₩-5445.43M | ₩10.25B | ₩3.11B | ₩-516.61M | ₩-4107.55M | ₩-8759.70M | ₩-18195.05M | ₩10.88B | ₩4.24B | ₩0.00M |
| FCF | Free Cash Flow |
|
₩-4777.86M | ₩-8714.71M | ₩8.36B | ₩2.00B | ₩-5617.50M | ₩-26567.67M | ₩-11313.96M | ₩-21793.39M | ₩7.45B | ₩972.08M | ₩0.00M |
| FCFS | Free Cash Flow Per Share |
|
₩-737.09 | ₩-990.52 | ₩852.97 | ₩207.99 | ₩-591.38 | ₩-2393.67 | ₩-538.41 | ₩-1034.47 | ₩350.01 | ₩-77.82 | ₩0.00 |